39 filings · most recent first
ABBV 8-K Filings
Abbvie Reports Strong Q2 2026 Financial Results And Announces Acquisition Of
Abbvie Inc Announces Acquired Iprd And Milestones Expense Impacting Q2 2026
Abbvie To Acquire Apogee Therapeutics In 109 Billion Deal
Abbvie Inc Announces Results Of 2026 Annual Meeting Of Stockholders
Abbvie Reports Firstquarter 2026 Financial Results And Raises Guidance
Abbvie Updates 2026 Earnings Guidance Due To Acquired Iprd And Milestones
Abbvie Completes Underwritten Public Offering Of Senior Notes
Abbvie Inc Announces Issuance Of Senior Notes
Abbvie Reports 2025 Financial Results And 2026 Outlook
Abbvie Discloses Impact Of Acquired Iprd And Milestones Expense On Q4 2025
Abbvie Announces Thirdquarter 2025 Financial Results And Raises Fullyear
Abbvie Announces Expected Third Quarter 2025 Acquired Iprd And Milestones
Abbvie Reports Q2 2025 Financial Results With Adjusted Eps Of 297
Abbvie Expects Earnings Impact Due To Acquired Iprd And Milestones Expense
Abbvie Reports Firstquarter 2025 Financial Results And Key Business Updates
Abbvie Announces Preliminary Q1 2025 Financial Results And Adjusts Guidance
Abbvie Reports 2024 Financial Results And Provides 2025 Outlook
Abbvie Announces Significant Impairment Charge For Emraclidine Asset
Abbvie Announces Fourthquarter And Fullyear 2024 Earnings Guidance Including
Abbvie Reports Q3 2024 Results With Increased Revenues And Adjusted Eps
Abbvie Inc Discloses Thirdquarter Earnings Impact
Abbvie Reports Q2 2024 Financial Results And Raises Guidance
Abbvie Inc Reports Unfavorable Impact On Earnings Due To Acquired Iprd And
Abbvie Announces Firstquarter 2024 Results And Leadership Transition
Abbvie Announces Expected Earnings Miss Due To Acquired Iprd And Milestones
Abbvie Reports 2023 Financial Results And Announces Acquisitions
Abbvie Announces 2023 Fourth Quarter Earnings Guidance Adjustment Due To
Abbvie Announces Settlement Of Litigation Over Upadacitinib
Abbvie Expands Board And Announces Leadership Changes
Abbvie Inc Completes Senior Notes Offering
Abbvie Inc Announces Issuance Of Senior Notes
Abbvie Elects Ceo As New Chairman
Abbvie Inc Enters Into Revolving Credit Agreement
Abbvie Appoints New Senior Vice President Controller
Abbvie Inc Updates Bylaws And Provides Financial Exhibits
Abbvie Appoints New Ceo And Announces 2024 Annual Meeting Results
Abbvie Announces 15 Billion Senior Notes Offering
Abbvie Appoints Robert A Michael As New Ceo
Abbvie Completes Acquisition Of Immunogen